Early assessment in Alzheimer's disease is crucial for protecting brain health and establishing an appropriate follow-up plan.
The Florence Nightingale Hospital Brain Health Package combines a consultation with a specialist physician and the P-Tau 217 blood test , which helps assess biological changes associated with Alzheimer's disease.
The P-Tau 217 result obtained from your blood sample will be evaluated by your specialist physician, along with your clinical findings and medical history, to help create a personalized treatment plan for you .
• Specialist Physician Consultation
What is the P-Tau 217 Blood Test?
P-Tau 217 is a blood-measurable biomarker that can provide information about biological changes in the brain associated with Alzheimer's disease.
Today, blood-based Alzheimer's biomarkers are playing an increasingly important role in expert evaluation, particularly in individuals with cognitive symptoms. P-Tau 217 is among the primary blood biomarkers used in the assessment of Alzheimer's pathology.
A standard blood sample is taken for the test. The results are used to support a comprehensive clinical evaluation by a physician specializing in Alzheimer's disease.
Why is early diagnosis important in Alzheimer's disease?
Biological changes associated with Alzheimer's disease (internal link: https://www.florence.com.tr/guncel-saglik/alzheimer-hastaligi) may begin in some individuals before noticeable cognitive symptoms appear. Advances in blood-based biomarkers offer new options to support the assessment process for individuals suspected of having Alzheimer's.
Especially;
• Forgetfulness,
• Difficulty remembering recent events,
• Changes in attention and concentration,
• Difficulty finding words,
• Difficulty planning daily tasks
If symptoms such as these are present, evaluation by a specialist physician is important.
How to Implement the Brain Health Package?
1. Your blood sample will be taken.
A blood sample will be taken to measure your P-Tau 217 level.
2. Your P-Tau 217 result will be evaluated.
Your blood sample will be analyzed for the P-Tau 217 biomarker, which is associated with Alzheimer's disease.
3. You will consult with your specialist physician.
Your test results, along with your age, medical history, cognitive symptoms, and other clinical findings, will be evaluated by your specialist physician.
4. A customized roadmap will be determined for you.
If your doctor deems it necessary, they may refer you for additional cognitive tests, advanced imaging techniques such as PET or MRI , or further evaluations.
Who can be evaluated for the P-Tau 217 Test?
The Brain Health Package specifically includes:
• Those experiencing forgetfulness or memory changes,
• Those who experience differences in their attention and cognitive functions,
• Those concerned about Alzheimer's and wishing to have their condition evaluated by a specialist physician,
• Individuals with a family history of Alzheimer's who wish to seek medical advice regarding their own brain health,
• For whom further evaluation for Alzheimer's is deemed appropriate by their physician
It can be evaluated for individuals.
Whether the test is suitable for you should be determined by a specialist physician.
Does the P-Tau 217 test diagnose Alzheimer's disease?
The P-Tau 217 test alone does not diagnose Alzheimer's disease.
The test results can provide the physician with information about the biological processes associated with Alzheimer's disease. An Alzheimer's assessment considers the individual's symptoms, clinical examination, cognitive tests, and other laboratory or imaging methods as needed. Current clinical guidelines also recommend the use of blood-based biomarkers as part of expert assessment.
Therefore, the Florence Nightingale Brain Health Package includes the P-Tau 217 blood test along with a consultation with a specialist physician.
Make an Appointment
E-Result
Let Us Call You